Amicus Therapeutics Files 2025 Proxy Statement
Ticker: FOLD · Form: DEF 14A · Filed: Apr 24, 2025 · CIK: 1178879
| Field | Detail |
|---|---|
| Company | Amicus Therapeutics, Inc. (FOLD) |
| Form Type | DEF 14A |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
Related Tickers: AMTX
TL;DR
Amicus Therapeutics (AMTX) filed its proxy statement for the June 5th meeting. Vote your shares!
AI Summary
Amicus Therapeutics, Inc. filed its definitive proxy statement on April 24, 2025, for its annual meeting of stockholders scheduled for June 5, 2025. The filing, designated as DEF 14A, outlines the company's governance and proposals to be voted on by shareholders. Key items likely include the election of directors and executive compensation.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, executive pay, and important corporate decisions, enabling them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is standard for public companies and does not inherently introduce new risks.
Key Players & Entities
- AMICUS THERAPEUTICS, INC. (company) — Registrant
- 0001140361-25-015479 (filing_id) — Accession Number
- 20250424 (date) — Filing Date
- 20250605 (date) — Meeting Date
- 47 HULFISH STREET (address) — Principal Business Address
- PRINCETON (location) — City
- NJ (location) — State
- 08542 (zip_code) — Zip Code
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the proxy statement for Amicus Therapeutics, Inc.'s annual meeting of stockholders, detailing information for voting on corporate matters.
When is the annual meeting of stockholders scheduled?
The annual meeting of stockholders is scheduled for June 5, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 24, 2025.
What is the company's principal business address?
The company's principal business address is 47 Hulfish Street, Princeton, NJ 08542.
What is the SEC file number for Amicus Therapeutics, Inc.?
The SEC file number for Amicus Therapeutics, Inc. is 001-33497.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 regarding AMICUS THERAPEUTICS, INC. (FOLD).